Literature DB >> 12767118

An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid.

Raimon Sabaté1, Montserrat Gallardo, Joan Estelrich.   

Abstract

Alzheimer's disease is the commonest form of senile dementia, affecting almost 20 million people worldwide. This neurodegenerative disorder is characterized by amyloid deposition in senile plaques, composed primarily of fibrils of an aggregated peptide, beta-amyloid. Fibrillation of beta-amyloid is a nucleation-dependent polymerization process, which is controlled by two kinetics parameters: the nucleation rate and the elongation or growth rate. As the kinetics of fibrillation is strongly dependent on the presence of trace amounts of fibrils, we suggest that the aggregation of beta-amyloid is a model of autocatalytic reaction. A mathematical analysis, permitting quantitative monitoring of the kinetics of fibrillogenesis of beta-amyloid, nucleation, and elongation constants, is presented. The model was checked by applying it to the aggregation of the fragment 1-40 of the beta-amyloid. Understanding of these rate constants may facilitate the study of the effect of substances used for controlling fibril creation and growth. The disaggregating effect of dodecyl trimethylammonium bromide, a cationic surfactant, was easily quantified by means of the model. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767118     DOI: 10.1002/bip.10441

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  15 in total

1.  Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.

Authors:  Olubukayo-Opeyemi Oyetayo; Hans Kiefer
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

2.  Formation kinetics of insulin-based amyloid gels and the effect of added metalloporphyrins.

Authors:  Robert F Pasternack; Esther J Gibbs; Scott Sibley; Lauren Woodard; Peter Hutchinson; Joseph Genereux; Kathleen Kristian
Journal:  Biophys J       Date:  2005-11-04       Impact factor: 4.033

3.  Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins.

Authors:  Jihoon Kim; Masaki Kobayashi; Makoto Fukuda; Daisuke Ogasawara; Natsuki Kobayashi; Sungwoong Han; Chikashi Nakamura; Masaki Inada; Chisato Miyaura; Kazunori Ikebukuro; Koji Sode
Journal:  Prion       Date:  2010-01-04       Impact factor: 3.931

4.  Inhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by Citrate.

Authors:  Yong Hoon Park; Young-Jin Kim; Il Hong Son; Hyun Duk Yang
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

5.  Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments.

Authors:  Samuel I A Cohen; Michele Vendruscolo; Mark E Welland; Christopher M Dobson; Eugene M Terentjev; Tuomas P J Knowles
Journal:  J Chem Phys       Date:  2011-08-14       Impact factor: 3.488

6.  Yeast prions form infectious amyloid inclusion bodies in bacteria.

Authors:  Alba Espargaró; Anna Villar-Piqué; Raimon Sabaté; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2012-06-25       Impact factor: 5.328

7.  Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion.

Authors:  Raimon Sabaté; Alba Espargaró; Sven J Saupe; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2009-10-28       Impact factor: 5.328

8.  Investigation of sickle-cell haemoglobin polymerisation under electrochemical control.

Authors:  Zeshan Iqbal; Matthew Li; Rachel McKendry; Michael Horton; Daren J Caruana
Journal:  Chemphyschem       Date:  2013-05-23       Impact factor: 3.102

9.  High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.

Authors:  Sabine Rauth; Dominik Hinz; Michael Börger; Markus Uhrig; Manuel Mayhaus; Matthias Riemenschneider; Arne Skerra
Journal:  Biochem J       Date:  2016-03-30       Impact factor: 3.857

10.  Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs.

Authors:  Alba Espargaró; Aina Medina; Ornella Di Pietro; Diego Muñoz-Torrero; Raimon Sabate
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.